Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride Patent Expiration

Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride is Used for relieving symptoms of seasonal and perennial allergic rhinitis. It was first introduced by Johnson And Johnson Consumer Inc Mcneil Consumer Healthcare Div in its drug Zyrtec-D 12 Hour on Nov 9, 2007. 6 different companies have introduced drugs containing Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride.


Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride Patents

Given below is the list of patents protecting Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zyrtec-d 12 Hour US6469009 Pharmaceutical compositions for the treatment of rhinitis Jul 13, 2019

(Expired)

 J And J Consumer Inc
Zyrtec-d 12 Hour US6489329 Pharmaceutical compositions for the treatment of rhinitis Apr 08, 2016

(Expired)

 J And J Consumer Inc
Zyrtec-d 12 Hour US7014867 Tablet comprising cetirizine and pseudoephedrine Jun 10, 2022

(Expired)

 J And J Consumer Inc
Zyrtec-d 12 Hour US7226614 Tablet comprising cetirizine and pseudoephedrine Jun 10, 2022

(Expired)

 J And J Consumer Inc


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 22 Nov, 2018 US7226614
Payment of Maintenance Fee, 12th Year, Large Entity 07 Sep, 2017 US7014867(Litigated)
Recordation of Patent Grant Mailed 05 Jun, 2007 US7226614
Patent Issue Date Used in PTA Calculation 05 Jun, 2007 US7226614
Issue Notification Mailed 16 May, 2007 US7226614
Dispatch to FDC 07 May, 2007 US7226614
Application Is Considered Ready for Issue 01 May, 2007 US7226614
Issue Fee Payment Received 25 Apr, 2007 US7226614
Issue Fee Payment Verified 25 Apr, 2007 US7226614
Mail Notice of Allowance 06 Apr, 2007 US7226614



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride Generics

Several generic applications have been filed for Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride. The first generic version for Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Feb 25, 2008. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Mar 8, 2023.

Given below is the list of companies who have filed for Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride generic.


1. PPI-DAC

Perrigo Pharma International Dac has filed for 1 generic for Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride. This 5mg;120mg version comes by the name CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Ppi-dac.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG; 120MG tablet, extended release Over the counter ORAL N/A Nov 16, 2018


2. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 1 generic for Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride. This 5mg;120mg version comes by the name CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG; 120MG tablet, extended release Discontinued ORAL N/A Mar 8, 2023


3. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride. This 5mg;120mg version comes by the name CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG; 120MG tablet, extended release Over the counter ORAL N/A Sep 28, 2012


4. IVAX SUB TEVA PHARMS

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 1 generic for Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride. This 5mg;120mg version comes by the name CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG; 120MG tablet, extended release Over the counter ORAL N/A Feb 25, 2008


5. PLD ACQUISITIONS

Pld Acquisitions Llc Dba Avema Pharma Solutions has filed for 1 generic for Cetirizine Hydrochloride; Pseudoephedrine Hydrochloride. This 5mg;120mg version comes by the name CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Pld Acquisitions.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG; 120MG tablet, extended release Over the counter ORAL N/A Mar 5, 2008